Literature DB >> 25670390

Review of cranial radiotherapy-induced vasculopathy.

Erin S Murphy1, Hao Xie, Thomas E Merchant, Jennifer S Yu, Samuel T Chao, John H Suh.   

Abstract

Cranial radiation can impact the cerebral vasculature in many ways, with a wide range of clinical manifestations. The incidence of these late effects including cerebrovascular accidents (CVAs), lacunar lesions, vascular occlusive disease including moyamoya syndrome, vascular malformations, and hemorrhage is not well known. This article reviews the preclinical findings regarding the pathophysiology of late radiation-induced vascular damage, and discusses the clinical incidence and risk factors for each type of vasculopathy. The pathophysiology is complex and dependent on the targeted blood vessels, and upregulation of pro-inflammatory and hypoxia-related genes. The risk factors for adult CVAs are similar to those for patients not exposed to cranial radiotherapy. For children, risks for late vascular complications include young age at radiotherapy, radiotherapy dose, NF1, tumor location, chemotherapy, and endocrine abnormalities. The incidence of late vascular complications of radiotherapy may be impacted by improved technology, therapeutic interventions, and appropriate follow up.

Entities:  

Mesh:

Year:  2015        PMID: 25670390     DOI: 10.1007/s11060-015-1732-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  53 in total

1.  Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage.

Authors:  Fiona Anne Stewart; Sylvia Heeneman; Johannes Te Poele; Jacqueline Kruse; Nicola S Russell; Marion Gijbels; Mat Daemen
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Hypoxia in radiation-induced blood-spinal cord barrier breakdown.

Authors:  Y Q Li; J R Ballinger; R A Nordal; Z F Su; C S Wong
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 3.  Radiation-induced damage in the central nervous system: an interpretation of target cell responses.

Authors:  A J van der Kogel
Journal:  Br J Cancer Suppl       Date:  1986

4.  Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.

Authors:  Sean M Lew; Joseph N Morgan; Estee Psaty; Daniel R Lefton; Jeffrey C Allen; Rick Abbott
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

5.  Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation.

Authors:  Miguel P Soares; Mark P Seldon; Isabel Pombo Gregoire; Tatiana Vassilevskaia; Pascal O Berberat; Jia Yu; Tung-Yu Tsui; Fritz H Bach
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 6.  Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy.

Authors:  Rolf-Dieter Kortmann; Beate Timmermann; Roger E Taylor; Giovanni Scarzello; Ludwig Plasswilm; Frank Paulsen; Branislav Jeremic; Astrid K Gnekow; Karin Dieckmann; Sylvia Kay; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2003-08       Impact factor: 3.621

7.  Risks of history of diabetes mellitus, hypertension, and other factors related to radiation-induced changes following Gamma Knife surgery for cerebral arteriovenous malformations.

Authors:  Mark Quigg; Chun-Po Yen; Micaela Chatman; Anders H Quigg; Ian T McNeill; Ian T Macneill; Colin J Przybylowski; Guofen Yan; Jason P Sheehan
Journal:  J Neurosurg       Date:  2012-12       Impact factor: 5.115

8.  Incidence of cerebral infarction after radiotherapy for pituitary adenoma.

Authors:  J C Flickinger; P B Nelson; F H Taylor; A Robinson
Journal:  Cancer       Date:  1989-06-15       Impact factor: 6.860

9.  Moyamoya phenomenon after radiation for optic glioma.

Authors:  J R Kestle; H J Hoffman; A R Mock
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

10.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

View more
  26 in total

Review 1.  Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.

Authors:  Patrick Y Wen; Michael Weller; Eudocia Quant Lee; Brian M Alexander; Jill S Barnholtz-Sloan; Floris P Barthel; Tracy T Batchelor; Ranjit S Bindra; Susan M Chang; E Antonio Chiocca; Timothy F Cloughesy; John F DeGroot; Evanthia Galanis; Mark R Gilbert; Monika E Hegi; Craig Horbinski; Raymond Y Huang; Andrew B Lassman; Emilie Le Rhun; Michael Lim; Minesh P Mehta; Ingo K Mellinghoff; Giuseppe Minniti; David Nathanson; Michael Platten; Matthias Preusser; Patrick Roth; Marc Sanson; David Schiff; Susan C Short; Martin J B Taphoorn; Joerg-Christian Tonn; Jonathan Tsang; Roel G W Verhaak; Andreas von Deimling; Wolfgang Wick; Gelareh Zadeh; David A Reardon; Kenneth D Aldape; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

Review 2.  Imaging findings in radiation therapy complications of the central nervous system.

Authors:  Tomonori Kanda; Yuichi Wakabayashi; Feibi Zeng; Yoshiko Ueno; Keitaro Sofue; Takaki Maeda; Munenobu Nogami; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2018-07-24       Impact factor: 2.374

Review 3.  Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.

Authors:  Milan T Makale; Carrie R McDonald; Jona A Hattangadi-Gluth; Santosh Kesari
Journal:  Nat Rev Neurol       Date:  2016-12-16       Impact factor: 42.937

4.  Radiotherapy-related intracranial aneurysm: case presentation of a 17-year male and a meta-analysis based on individual patient data.

Authors:  Yuan-Hung Wu; Sheng-Shuan Lin; Hsin-Hung Chen; Feng-Chi Chang; Muh-Lii Liang; Tai-Tong Wong; Sang-Hue Yen; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2016-06-15       Impact factor: 1.475

Review 5.  Stroke-Like Migraine Attacks After Radiation Therapy (SMART) Syndrome: A Comprehensive Review.

Authors:  Moises Dominguez; Rachna Malani
Journal:  Curr Pain Headache Rep       Date:  2021-03-24

6.  Mechanical Thrombectomy and Stenting for Radiation-Induced Carotid Stenosis-Related Stroke: A Case Report.

Authors:  Yu-Chen Cheng; Wei-Cheng Lin; Chia-Nan Lin; Hou-Chang Chiu
Journal:  Case Rep Neurol       Date:  2020-12-14

7.  A Case of Occlusive Radiation Vasculopathy Presenting as Bilateral Internal Carotid Artery, Left Middle Cerebral Artery Occlusion and Literature Review.

Authors:  Yung-Chuan Huang; Shin-Leh Huang; Hon-Man Liu; Hou-Chang Chiu
Journal:  Case Rep Neurol       Date:  2020-12-14

8.  Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Primary Brain Tumors.

Authors:  Neal S Parikh; Jaclyn E Burch; Hooman Kamel; Lisa M DeAngelis; Babak B Navi
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-06-21       Impact factor: 2.136

9.  Mechanisms of post-radiation injury: cerebral microinfarction not a significant factor.

Authors:  J A Molad; D T Blumenthal; F Bokstein; M Findler; I Finkel; N M Bornstein; S Yust-Katz; E Auriel
Journal:  J Neurooncol       Date:  2016-10-18       Impact factor: 4.130

10.  Long-term survival among 5-year survivors of adolescent and young adult cancer.

Authors:  Amy M Berkman; J A Livingston; Kelly Merriman; Michelle Hildebrandt; Jian Wang; Seyedeh Dibaj; Jennifer McQuade; Nancy You; Anita Ying; Carlos Barcenas; Diane Bodurka; April DePombo; Hun Ju Lee; John de Groot; Michael Roth
Journal:  Cancer       Date:  2020-06-02       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.